Meeting the global demand for seafood is more essential than ever as the world’s population continues to increase. Not only is the need for protein increasing but so are the demands of consumers who expect more accountability and transparency in how their seafood is produced. Consumers today expect producers and suppliers to meet their seafood demands, and to do so in a manner where production practices are ethical and humane and protective of the planet’s natural resources.
How can these separate and complicated demands be supported as stakeholders meet the growing need for food security? Many of the answers lie in today’s advancements and adoption of technology.
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, has expanded its biopharma portfolio to include innovative vaccines, DNA-based traceability solutions for aquaculture producers, processors, and retailers as well as technology valued by conservationists that provides insightful data used to manage fish populations in critical habitats throughout the world.
Meeting today’s protein and seafood demands and the high expectations of consumers and conservationists, requires a new and holistic approach to seafood health and production that is accomplished through a portfolio of biopharma and technology solutions.